Vanta Bioscience Limited IPO

Apply 0
Avoid 0

Vanta Bioscience Ltd (VBL) is a preclinical contract research company which offers safety assessment services for clientele from Pharmaceutical, Medical Devices, Nutraceuticals, Feed Additive, Biotech, Agrochemicals, Cosmetics, and Chemical industries.
In addition, they also provide risk assessment services for evaluating the safety of the Active Pharmaceutical Ingredients (API), excipients, extractable and leachable including pharmaceutical impurities resulting due to the manufacturing process or due to degradation of the product. VBL also provides expert services for a determination of health-based exposure limits (e.g. permitted daily exposure (PDE) or allowable daily exposure (ADE) including occupational exposure limits (OEL) for pharmaceutical manufacturers. Their services include toxicology, batch release tests, biocompatibility studies, chemical safety, and diet formulation.
One of the major services of VBL is conducting a variety of in vitro (cell, tissue and organisms) and in vivo (animal) toxicology studies for its diverse clients as per various regulatory requirements from across the world. Toxicology is a branch of biology, chemistry, and pharmacology concerned with the study of the adverse effects of chemicals on living organisms. It also studies the harmful effects of chemical, biological and physical agents in biological systems that establish the extent of damage in living organisms. The relationship between dose and its effects on the exposed organism is of high significance in toxicology. Toxicology and safety assessment are sometimes used interchangeably and considered as synonymous.
Vanta Bioscience based in Des Moines, Iowa with additional offices in Brussels, Belgium; and West Des Moines, Iowa. It has a toxicology research facility in Chennai, India.

Vanta Bioscience Limited IPO Stock Quote & Charts

92.00

-2.13%

  • Open: 93.00
  • High - Low: 93.00 - 92.00
  • Previous Close: 94.00
  • Total Traded Volume: 3000
  • Updated On: 12-Nov-2018

Objects of the Vanta Bioscience Limited IPO:

1. Augmenting additional working capital requirements 2. General Corporate Purposes

Vanta Bioscience Limited IPO Details:

Open Date: Sep 25 2017
Close Date: Sep 27 2017
Total Shares: 1,512,000
Face Value: ₹ 10 Per Equity Share
Issue Type: Fixed Price Issue IPO
Issue Size: 7.56 Cr.
Lot Size: 3000 Shares
Issue Price: ₹ 50 Per Equity Share
Listing At: BSE SME
Listing Date: Oct 06 2017

Promoters And Management:

1. Mohan Krishna Mulakala 2. Dopesh Raja Mulakala 3. Dr Vyasmurti Madhavrao Shingatgeri 4. Dr. Soumya Simhadri 5. Shravan Chintapatla 6. Karishma Mulakala 7. Sajan Kiran Mulakala 8. Pradeep Chowdary and 9. Dr. Chandrasekhar Rao Simhadri

Lead Manager of Vanta Bioscience Limited IPO:

  1. Inventure Merchant Banker Services Private Limited

Registrar of Vanta Bioscience Limited IPO:

  1. Bigshare Services Private Limited

Company Address:

Vanta Bioscience Limited NO 02/G/308/G, NO 3/FF/SF/1-20-248 Umajay Complex, Rasoolpura, Secunderabad, Hyderabad – 500 003 Phone: +91 40 6657 5454 Fax: +91 40 2790 8708 Email: info@vantabio.com Website: www.vantabio.com

25th Sep 2018 - 27th Sep 2018 => Aavas Financiers IPO

Discussion on Vanta Bioscience Limited IPO: